Guardant Health Inc (NASDAQ: GH) on Monday, soared 5.53% from the previous trading day, before settling in for the closing price of $105.42. Within the past 52 weeks, GH’s price has moved between $29.91 and $110.00.
During the last 5-year period, the sales drop of Healthcare Sector giant was -33.61%. The company achieved an average annual earnings per share of 13.27%. With a float of $124.15 million, this company’s outstanding shares have now reached $125.01 million.
Guardant Health Inc (GH) Insider Activity
Observing investor behavior towards Diagnostics & Research industry stocks is more important than anything else. The insider ownership of Guardant Health Inc is 4.04%, while institutional ownership is 96.59%. The most recent insider transaction that took place on Nov 19 ’25, was worth 11,165. In this transaction Director of this company sold 116 shares at a rate of $96.25, taking the stock ownership to the 7,859 shares. Before that another transaction happened on Nov 19 ’25, when Company’s Director proposed sale 116 for $96.25, making the entire transaction worth $11,165.
Guardant Health Inc (GH) Earnings and Forecasts
As on 12/31/2024, Multinational firm has announced its last quarter scores, in which it reported -0.62 earnings per share (EPS) for the period falling under the consensus outlook (set at -0.5) by -0.12. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.44 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 13.27% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 20.42% during the next five years compared to -33.61% drop over the previous five years of trading.
Guardant Health Inc (NASDAQ: GH) Trading Performance Indicators
Guardant Health Inc (GH) is currently performing well based on its current performance indicators. A quick ratio of 3.12 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 15.95.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.21, a number that is poised to hit -0.78 in the next quarter and is forecasted to reach -2.76 in one year’s time.
Technical Analysis of Guardant Health Inc (GH)
Looking closely at Guardant Health Inc (NASDAQ: GH), its last 5-days average volume was 3.59 million, which is a jump from its year-to-date volume of 2.49 million. As of the previous 9 days, the stock’s Stochastic %D was 74.64%.
During the past 100 days, Guardant Health Inc’s (GH) raw stochastic average was set at 99.08%, which indicates a significant increase from 97.13% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 6.09 in the past 14 days, which was higher than the 3.13 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $76.07, while its 200-day Moving Average is $54.66. However, in the short run, Guardant Health Inc’s stock first resistance to watch stands at $113.99. Second resistance stands at $116.73. The third major resistance level sits at $121.55. If the price goes on to break the first support level at $106.43, it is likely to go to the next support level at $101.61. Should the price break the second support level, the third support level stands at $98.87.
Guardant Health Inc (NASDAQ: GH) Key Stats
Market capitalization of the company is 14.39 billion based on 126,041K outstanding shares. Right now, sales total 739,020 K and income totals -436,370 K. The company made 265,200 K in profit during its latest quarter, and -92,730 K in sales during its previous quarter.
